Important note

This AI stock analysis for GE HealthCare is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

GE HealthCare - AI Stock Analysis

Analysis generated May 23, 2024

GE HealthCare is a leading global medical technology and digital solutions innovator. The company provides a diversified portfolio of products such as imaging, ultrasound, software & IT, patient monitoring and diagnostics, drug discovery, and biomanufacturing. GE HealthCare aims to enable precision health—personalized, connected and efficient. Its strong market position has been fueled by technological advancements, strategic acquisitions, and solid R&D capabilities.

Fundamental Analysis

GE HealthCare reported a revenue of $4.65 billion for the last quarter. Comparing this to the previous quarter, there is a slight increase of 0.96%, which is a mildly positive indication of growth. However, when compared to the same quarter last year, there is a decline of 1.21%, which may cause some concern.

The net income for the last quarter was $374 million. This represents a 7.20% decrease compared to the prior quarter but a small increase of 0.54% year-over-year. Although the quarterly drop is concerning, the year-over-year increment suggests some positive movement over a more extended timeframe.

GE HealthCare recorded an EBITDA of $620 million for the last quarter. This figure indicates a decrease of 19.79% from the previous quarter and a 5.34% drop year-over-year, signaling a potential issue with efficiency or cost management.

The current Price to Earnings (P/E) ratio stands at 23.49. This ratio is within a normal range and does not signify any extreme valuation—neither particularly high nor low.

Technical Analysis

Today’s stock price is $79.33, which is an 8.01% decrease from a month ago, indicating potential short-term volatility. However, on a more positive note, the price has increased by 3.82% compared to a year ago, suggesting a positive long-term trend.

The stock appears to be in a bearish trend. The current Simple Moving Average (SMA10) is 81.30, slightly lower than the prior SMA10 of 81.47, adding to the notion of a potential downward trend. The Relative Strength Index (RSI) is 65.6, indicating a neutral market condition.

Alternative Data Analysis

In terms of alternative data, GE HealthCare has approximately 1,200 open job positions, up by 18% in the last couple of months, which could signify growth and expansion prospects. Employee sentiment towards the company remains neutral.

The company’s website has seen an estimated 1.5 million visitors, up 18% in the past couple of months, indicating a growth in customer interest and potentially in acquiring new customers.

On social media, GE HealthCare has 58,000 followers on Instagram, up by 5%, indicating increased interest. Their Twitter following remains at 120,000, with no percentage change, showcasing stable but flat interest.

According to AltIndex's AI score, which combines fundamental, technical, and alternative data, GE HealthCare scores a 56, which indicates a 'hold' recommendation.

Conclusion and Recommendation

Based on multiple analytical perspectives, GE HealthCare shows a mixed set of signals.

The fundamental analysis reveals a solid revenue base with concerning efficiency metrics as seen in EBITDA. The slight increases in revenue and net income year-over-year are positive, but the overall mixed performance presents caution.

The technical analysis suggests a bearish short-term trend, although the long-term prices have grown, indicating the stock may face recent volatility but could solidify for long-term gains.

The alternative data points are also ambivalent, suggesting growth in job postings and web traffic, indicating expansion, while employee sentiment remains neutral and social media engagement shows mixed results.

On balance, combining all data provided, my recommendation aligns with the AI score of holding this stock. Investors should monitor the upcoming quarters for any signs of improved operational efficiency and consider potential long-term holds given the slow but positive year-over-year growth.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.